²é¿´: 1403  |  »Ø¸´: 8
µ±Ç°Ö»ÏÔʾÂú×ãÖ¸¶¨Ìõ¼þµÄ»ØÌû£¬µã»÷ÕâÀï²é¿´±¾»°ÌâµÄËùÓлØÌû

angelhunte

Ìú¸Ëľ³æ (ÕýʽдÊÖ)

²ËÄñ

[ÇóÖú] »ÔÈðÐÂÉÏÊеÄÐÂÒ©crizotinibµÄALKøÒÖÖÆÂÊÊǶàÉÙ£¬Èç¹ûÓÐÎÄÏ×»á×·¼Ó100½ð±Ò

»ÔÈðÐÂÉÏÊеÄÐÂÒ©crizotinibµÄALKøÒÖÖÆÂÊÊǶàÉÙ£¬Èç¹ûÓÐÎÄÏ×»á×·¼Ó100½ð±Ò
»Ø¸´´ËÂ¥
Çó¹¤×÷
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

С¶¬¹ÏÝæÝæ

Òø³æ (³õÈëÎÄ̳)

¡¾´ð°¸¡¿Ó¦Öú»ØÌû

¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï
¸Ðл²ÎÓ룬ӦÖúÖ¸Êý +1
angelhunte: ½ð±Ò+8, ¡ïÓаïÖú, ÖÁÉÙ˵Ã÷ÄúÈÏÕæ¿´¹ý 2012-09-18 22:37:21
³ÕÒÄ×ÓÆ¤: ½ð±Ò+2, лл½»Á÷£¬»¶Ó­³£À´Å¶¡£ 2012-09-20 08:32:59
»¹ÊÇÎÒÀ´Ó¦´ð°É£¡
crizotinibµÄALKøÒÖÖÆÂÊ99%£¨1΢Ħ¶ûŨ¶ÈÏ£©£¬ALKøÒÖÖÆIC50СÓÚ1nm¡£
²Î¿¼ÎÄÏ×£ºJournal of Medicinal chemistry 2011£¬ 54£¬ 6342-6363£¨Table¡£5.£©
4Â¥2012-09-18 16:41:24
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
²é¿´È«²¿ 9 ¸ö»Ø´ð

songxiangen

½ð³æ (СÓÐÃûÆø)

¡¾´ð°¸¡¿Ó¦Öú»ØÌû

¡ï
¸Ðл²ÎÓ룬ӦÖúÖ¸Êý +1
³ÕÒÄ×ÓÆ¤: ½ð±Ò+1, лл½»Á÷£¬»¶Ó­³£À´Å¶¡£ 2012-09-20 08:32:53
Crizotinib (PF-02341066) µÄÉúÎï»îÐÔ
Inhibitor of the catalytic activity of c-Met kinase and the NPM-ALK(nucleophosmin-anaplastic lymphoma kinase) fusion protein.[1] A t(2;5) chromosomal translocation resulting in expression of an oncogenic kinase fusion protein known as NPM-ALK has been implicated in the pathogenesis of anaplastic large-cell lymphoma (ALCL). [2]
After incubation with Crizotinib (PF-02341066), cells were washed once with HBSS supplemented with 1 mmol/L Na3VO4 and protein lysates were generated. Subsequently, phosphorylation of ALK was assessed by a sandwich ELISA method using an immobilized anti¨Ctotal-ALK antibody and an anti¨Cphospho-ALK antibody (pY1604) as a detec ion antibody.
Crizotinib (PF-02341066) inhibited NPM-ALKphosphorylation in Karpas299 or SU-DHL-1 ALCL cells (mean IC50 value=24 nM).
Crizotinib (PF-02341066) potently inhibited cell proliferation, which was associated with G1-S¨Cphase cell cycle arrest and induction of apoptosis in ALK-positive ALCL cells (IC50 values=30 nM) but not ALK-negative lymphoma cells. The induction of apoptosis was confirmed using terminal deoxyribonucleotide transferase¨Cmediated nick-end labeling and Annexin V staining (IC50 values=25¨C50 nM). [3]

Crizotinib (PF-02341066) ²Î¿¼ÎÄÏ×
[1] Blood 2005;105: 2640-2653
[2] Oncogene 2001;20:5623-5637
[3] Mol Cancer Ther 2007;6:3314-3322

²»ÖªµÀ¶ÔÂ¥Ö÷ÓÐûÓÐÓÃ
2Â¥2012-09-18 11:35:33
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

angelhunte

Ìú¸Ëľ³æ (ÕýʽдÊÖ)

²ËÄñ

ÒýÓûØÌû:
2Â¥: Originally posted by songxiangen at 2012-09-18 11:35:33
Crizotinib (PF-02341066) µÄÉúÎï»îÐÔ
Inhibitor of the catalytic activity of c-Met kinase and the NPM-ALK(nucleophosmin-anaplastic lymphoma kinase) fusion protein. A t(2;5) chromosomal translocation r ...

ϸ°û»îÐÔ£¬ÎÒÒªµÄÊÇø»îÐÔ£¬Óб¨µÀ˵СÓÚ1nM,µ«²»ÖªµÀ¾ßÌåÊý¾Ý
Çó¹¤×÷
3Â¥2012-09-18 15:02:27
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

С¶¬¹ÏÝæÝæ

Òø³æ (³õÈëÎÄ̳)

¡¾´ð°¸¡¿Ó¦Öú»ØÌû

¡ï
³ÕÒÄ×ÓÆ¤: ½ð±Ò+1, ÈÈÐĽ±Àø 2012-09-20 08:33:12
¼û¸½¼þͼƬÊý¾Ý

crizotinib.JPG

5Â¥2012-09-18 16:49:33
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
×î¾ßÈËÆøÈÈÌûÍÆ¼ö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[¿¼ÑÐ] 085601²ÄÁϹ¤³Ìר˶Çóµ÷¼Á +5 Ľº®mio 2026-03-16 5/250 2026-03-17 21:31 by hmn_wj
[¿¼ÑÐ] 268Çóµ÷¼Á +8 Ò»¶¨ÓÐѧÉÏ- 2026-03-14 9/450 2026-03-17 17:47 by laoshidan
[¿¼ÑÐ] 293Çóµ÷¼Á +6 ÊÀ½çÊ׸» 2026-03-11 6/300 2026-03-17 17:04 by ruiyingmiao
[¿¼ÑÐ] 275Çóµ÷¼Á +4 Ì«Ñô»¨ÌìÌ쿪ÐÄ 2026-03-16 4/200 2026-03-17 10:53 by ¹¦·ò·è¿ñ
[¿¼ÑÐ] 0854¿ØÖƹ¤³Ì 359Çóµ÷¼Á ¿É¿çרҵ +3 626776879 2026-03-14 9/450 2026-03-16 17:42 by 626776879
[¿¼ÑÐ] Ò»Ö¾Ô¸211 0703·½Ïò310·ÖÇóµ÷¼Á +3 ŬÁ¦·Ü¶·112 2026-03-15 3/150 2026-03-16 16:44 by houyaoxu
[¿¼ÑÐ] 070303 ×Ü·Ö349Çóµ÷¼Á +3 LJY9966 2026-03-15 5/250 2026-03-16 14:24 by xwxstudy
[¿¼ÑÐ] 0703 ÎïÀí»¯Ñ§µ÷¼Á +3 ÎÒ¿ÉÒÔÉϰ¶µÄ¶Ô 2026-03-13 5/250 2026-03-16 10:50 by ÎÒ¿ÉÒÔÉϰ¶µÄ¶ÔÂ
[¿¼ÑÐ] ¸´ÊÔµ÷¼Á +3 ºôºô£¿~+123456 2026-03-14 3/150 2026-03-14 16:53 by WTUChen
[¿¼ÑÐ] Ò»Ö¾Ô¸¹þ¹¤´ó²ÄÁÏ324·ÖÇóµ÷¼Á +5 ãÆÐñ¶« 2026-03-14 5/250 2026-03-14 14:53 by ľ¹Ï¸à
[¿¼ÑÐ] ²ÄÁÏ080500µ÷¼ÁÇóÊÕÁô +3 Ò»¿Åmeteor 2026-03-13 3/150 2026-03-14 10:54 by peike
[¿¼ÑÐ] Çó²ÄÁϵ÷¼Á 085600Ó¢Ò»Êý¶þ×Ü·Ö302 ǰÈý¿Æ235 ¾«Í¨»úÆ÷ѧϰ Ò»Ö¾Ô¸¹þ¹¤´ó +4 ÁÖyaxin 2026-03-12 4/200 2026-03-13 22:04 by ÐÇ¿ÕÐÇÔÂ
[¿¼ÑÐ] 26µ÷¼Á/²ÄÁÏ/Ó¢Ò»Êý¶þ/×Ü·Ö289/ÒѹýAÇøÏß +6 ²½´¨¿á×Ï123 2026-03-13 6/300 2026-03-13 21:59 by ÐÇ¿ÕÐÇÔÂ
[¿¼ÑÐ] ¡¾¿¼Ñе÷¼ÁÇóÊÕÁô¡¿ +3 Ceciilia 2026-03-11 3/150 2026-03-13 20:18 by JourneyLucky
[¿¼ÑÐ] ²ÄÁϹ¤³Ìµ÷¼Á +4 ßäßä¿Õ¿Õ 2026-03-11 4/200 2026-03-13 19:57 by JourneyLucky
[¿¼ÑÐ] 0703»¯Ñ§Çóµ÷¼Á +7 Â̶¹ÇÛ²ËÌÀ 2026-03-12 7/350 2026-03-13 17:25 by njzyff
[¿¼ÑÐ] ¹¤¿Æ²ÄÁÏ085601 279Çóµ÷¼Á +8 À§ÓÚÐdz¿ 2026-03-12 10/500 2026-03-13 15:42 by ms629
[¿¼ÑÐ] 295Çóµ÷¼Á +3 Сذ×ÐÖ­ 2026-03-12 3/150 2026-03-13 15:17 by vgtyfty
[¿¼ÑÐ] Çóµ÷¼Á +3 ³ÌÓ꺼 2026-03-12 3/150 2026-03-13 15:06 by JourneyLucky
[¿¼ÑÐ] 290Çóµ÷¼Á +3 ADT 2026-03-13 3/150 2026-03-13 10:19 by peike
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û